Shohreh Fahimirad

Dr. Shohreh Fahimirad


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2021 in Carbohydrate Polymers
Verified
Journal Article
Closed access
SFShohreh Fahimirad
Shohreh Fahimirad
HAHamid Abtahi
Hamid Abtahi
PSParastu Satei
Parastu Satei
EGEhsanollah Ghaznavi-Rad
Ehsanollah Ghaznavi-Rad
MMMohsen Moslehi
Mohsen Moslehi
AGAli Ganji
Ali Ganji

1 July 2019 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
SFShohreh Fahimirad
Shohreh Fahimirad
FAFatemeh Ajalloueian
Fatemeh Ajalloueian

1 January 2021 in Science of The Total Environment
Verified
Journal Article
Closed access
SFShohreh Fahimirad
Shohreh Fahimirad
ZFZahra Fahimirad
Zahra Fahimirad
Mika E.T. SillanpääMika E.T. Sillanpää
Mika E.T. Sillanpää

1 January 2019 in Ecotoxicology and Environmental Safety
Verified
Journal Article
Closed access
SFShohreh Fahimirad
Shohreh Fahimirad
Fatemeh AjalloUeianFatemeh AjalloUeian
Fatemeh AjalloUeian
MGMansour Ghorbanpour
Mansour Ghorbanpour

16 March 2024 in Cancer Cell International
Verified
Journal Article
Open access
PDF file
FMFatemeh Mahmoudian
Fatemeh Mahmoudian
AAAzin Ahmari
Azin Ahmari
SSShiva Shabani
Shiva Shabani
BSBahman Sadeghi
Bahman Sadeghi
SFShohreh Fahimirad
Shohreh Fahimirad
FFFahimeh Fattahi
Fahimeh Fattahi
Conventional cancer treatments can cause serious side effects because they are not specific to cancer cells and can damage healthy cells. Aptamers often are single-stranded oligonucleotides arranged in a unique architecture, allowing them to bind specifically to target sites. This feature makes them an ideal choice for targeted therapeutics. They are typically produced through the systematic evolution of ligands by exponential enrichment (SELEX) and undergo extensive pharmacological revision to modify their affinity, specificity, and therapeutic half-life. Aptamers can act as drugs themselves, directly inhibiting tumor cells. Alternatively, they can be used in targeted drug delivery systems to transport drugs directly to tumor cells, minimizing toxicity to healthy cells. In this review, we will discuss the latest and most advanced approaches to using aptamers for cancer treatment, particularly targeted therapy overcoming resistance to conventional therapies.

31 May 2017 in Molecules
Verified
Journal Article
Open access
PDF file
SFShohreh Fahimirad
Shohreh Fahimirad
HAHamid Abtahi
Hamid Abtahi
SRSeyed Hadi Razavi
Seyed Hadi Razavi
HAHoushang Alizadeh
Houshang Alizadeh
MGMansour Ghorbanpour
Mansour Ghorbanpour
Accelerating emergence of antimicrobial resistance among food pathogens and consumers’ increasing demands for preservative-free foods are two contemporary challenging aspects within the food industry. Antimicrobial packaging and the use of natural preservatives are promising solutions. In the present study, we used beta-casein—one of the primary self-assembly proteins in milk with a high polymeric film production capability—as a fusion partner for the recombinant expression of E 50-52 antimicrobial peptide in Escherichia coli. The pET21a-BCN-E 50-52 construct was transformed to E. coli BL21 (DE3), and protein expression was induced under optimized conditions. Purified protein obtained from nickel affinity chromatography was refolded under optimized dialysis circumstances and concentrated to 1600 µg/mL fusion protein by ultrafiltration. Antimicrobial activities of recombinant BCN-E 50-52 performed against Escherichia coli, Salmonella typhimurium, Listeria monocytogenes, Staphylococcus aureus, Aspergillus flavus, and Candida albicans. Subsequently, the synergistic effects of BCN-E 50-52 and thymol were assayed. Results of checkerboard tests showed strong synergistic activity between two compounds. Time–kill and growth kinetic studies indicated a sharp reduction of cell viability during the first period of exposure, and SEM (scanning electron microscope) results validated the severe destructive effects of BCN E 50-52 and thymol in combination on bacterial cells.